Search

everythinglearnresearchcommunity

for

Search:↓

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Provenge extends prostate cancer survival by about 4 months.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Finasteride is more harmful to male reproductive health than minoxidil.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

Hair loss linked to prostate enlargement; stress and family history important factors.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Treatments for urinary symptoms often cause ejaculatory problems.